We've found
4,483
archived clinical trials in
Influenza
We've found
4,483
archived clinical trials in
Influenza
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Click here to add this to my saved trials

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Click here to add this to my saved trials

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Click here to add this to my saved trials

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Click here to add this to my saved trials

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Click here to add this to my saved trials

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Click here to add this to my saved trials

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Click here to add this to my saved trials

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Click here to add this to my saved trials

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Click here to add this to my saved trials

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Click here to add this to my saved trials

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Click here to add this to my saved trials

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Click here to add this to my saved trials

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Click here to add this to my saved trials

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Updated: 9/3/2015
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
Click here to add this to my saved trials

TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations
Updated: 9/6/2015
TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Population
Status: Enrolling
Updated: 9/6/2015
TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations
Updated: 9/6/2015
TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Population
Status: Enrolling
Updated: 9/6/2015
Click here to add this to my saved trials

Influenza Vaccine in Premature Infants
Updated: 9/15/2015
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
Influenza Vaccine in Premature Infants
Updated: 9/15/2015
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials

Influenza Vaccine in Premature Infants
Updated: 9/15/2015
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
Influenza Vaccine in Premature Infants
Updated: 9/15/2015
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials

Influenza Vaccine in Premature Infants
Updated: 9/15/2015
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
Influenza Vaccine in Premature Infants
Updated: 9/15/2015
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials

Influenza Vaccine in Premature Infants
Updated: 9/15/2015
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
Influenza Vaccine in Premature Infants
Updated: 9/15/2015
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials

Influenza Vaccine in Premature Infants
Updated: 9/15/2015
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
Influenza Vaccine in Premature Infants
Updated: 9/15/2015
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
Updated: 9/16/2015
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine (2014-2015 Formulation)
Status: Enrolling
Updated: 9/16/2015
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
Updated: 9/16/2015
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine (2014-2015 Formulation)
Status: Enrolling
Updated: 9/16/2015
Click here to add this to my saved trials

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
Updated: 9/16/2015
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine (2014-2015 Formulation)
Status: Enrolling
Updated: 9/16/2015
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
Updated: 9/16/2015
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine (2014-2015 Formulation)
Status: Enrolling
Updated: 9/16/2015
Click here to add this to my saved trials

Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Updated: 9/16/2015
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated: 9/16/2015
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Updated: 9/16/2015
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated: 9/16/2015
Click here to add this to my saved trials

Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Updated: 9/16/2015
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated: 9/16/2015
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Updated: 9/16/2015
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated: 9/16/2015
Click here to add this to my saved trials

Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Updated: 9/16/2015
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated: 9/16/2015
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Updated: 9/16/2015
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated: 9/16/2015
Click here to add this to my saved trials

Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Updated: 9/16/2015
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated: 9/16/2015
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Updated: 9/16/2015
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated: 9/16/2015
Click here to add this to my saved trials

Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People
Updated: 9/17/2015
Evaluation of Anti-Hemagglutinin Antibodies as a Correlate of Protection in an H1N1 Influenza Healthy Human Challenge Model
Status: Enrolling
Updated: 9/17/2015
Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People
Updated: 9/17/2015
Evaluation of Anti-Hemagglutinin Antibodies as a Correlate of Protection in an H1N1 Influenza Healthy Human Challenge Model
Status: Enrolling
Updated: 9/17/2015
Click here to add this to my saved trials

A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Click here to add this to my saved trials

A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Click here to add this to my saved trials

A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Click here to add this to my saved trials

A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Click here to add this to my saved trials

A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Click here to add this to my saved trials

A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Click here to add this to my saved trials

A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Click here to add this to my saved trials

A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Click here to add this to my saved trials

A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Click here to add this to my saved trials

A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Click here to add this to my saved trials

A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Updated: 9/20/2015
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Click here to add this to my saved trials

Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children
Updated: 9/22/2015
Evaluation of the Effect of Age and Prior Immunity on the Response to Live or Inactivated A/California/07/09 H1N1 Influenza Vaccines in Children
Status: Enrolling
Updated: 9/22/2015
Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children
Updated: 9/22/2015
Evaluation of the Effect of Age and Prior Immunity on the Response to Live or Inactivated A/California/07/09 H1N1 Influenza Vaccines in Children
Status: Enrolling
Updated: 9/22/2015
Click here to add this to my saved trials

Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults
Updated: 9/24/2015
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent Virus-like-particle (VLP) Influenza Vaccine in Adults
Status: Enrolling
Updated: 9/24/2015
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults
Updated: 9/24/2015
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent Virus-like-particle (VLP) Influenza Vaccine in Adults
Status: Enrolling
Updated: 9/24/2015
Click here to add this to my saved trials

Alternative Oseltamivir Dosing Strategies
Updated: 9/26/2015
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated: 9/26/2015
Alternative Oseltamivir Dosing Strategies
Updated: 9/26/2015
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated: 9/26/2015
Click here to add this to my saved trials

Alternative Oseltamivir Dosing Strategies
Updated: 9/26/2015
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated: 9/26/2015
Alternative Oseltamivir Dosing Strategies
Updated: 9/26/2015
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated: 9/26/2015
Click here to add this to my saved trials

Alternative Oseltamivir Dosing Strategies
Updated: 9/26/2015
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated: 9/26/2015
Alternative Oseltamivir Dosing Strategies
Updated: 9/26/2015
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated: 9/26/2015
Click here to add this to my saved trials

Alternative Oseltamivir Dosing Strategies
Updated: 9/26/2015
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated: 9/26/2015
Alternative Oseltamivir Dosing Strategies
Updated: 9/26/2015
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated: 9/26/2015
Click here to add this to my saved trials

A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy
Updated: 9/28/2015
A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy
Status: Enrolling
Updated: 9/28/2015
A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy
Updated: 9/28/2015
A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy
Status: Enrolling
Updated: 9/28/2015
Click here to add this to my saved trials

A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
Updated: 9/29/2015
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
Updated: 9/29/2015
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
Click here to add this to my saved trials

A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
Updated: 9/29/2015
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
Updated: 9/29/2015
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
Click here to add this to my saved trials

A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
Updated: 9/29/2015
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
Updated: 9/29/2015
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
Click here to add this to my saved trials

A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
Updated: 9/29/2015
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
Updated: 9/29/2015
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
Click here to add this to my saved trials

A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
Updated: 9/29/2015
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
Updated: 9/29/2015
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
Click here to add this to my saved trials
